Data on effectiveness of the BioNTech/Pfizer COVID-19 vaccine in real-world settings are limited. In a study of 6,423 healthcare workers in Treviso Province, Italy, we estimated that, within the time intervals of 14–21 days from the first and at least 7 days from the second dose, vaccine effectiveness in preventing SARS-CoV-2 infection was 84% (95% confidence interval (CI): 40–96) and 95% (95% CI: 62–99), respectively. These results could support the ongoing vaccination campaigns by providing evidence for targeted communication.
All Keywords
【저자키워드】 Healthcare workers, SARS-COV-2 infection, Italy, COVID-19 disease, vaccine effectiveness, 【초록키워드】 Vaccine, COVID-19 vaccine, vaccination, healthcare worker, Effectiveness, Evidence, time interval, Support, 95% confidence interval, second dose, 【제목키워드】 Vaccine, BNT162b2, healthcare, Veneto,
【저자키워드】 Healthcare workers, SARS-COV-2 infection, Italy, COVID-19 disease, vaccine effectiveness, 【초록키워드】 Vaccine, COVID-19 vaccine, vaccination, healthcare worker, Effectiveness, Evidence, time interval, Support, 95% confidence interval, second dose, 【제목키워드】 Vaccine, BNT162b2, healthcare, Veneto,